Details
Stereochemistry | ACHIRAL |
Molecular Formula | C21H25FN2O2 |
Molecular Weight | 356.4338 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=C(C=CC=C1)N2CCN(CCCC(=O)C3=CC=C(F)C=C3)CC2
InChI
InChIKey=IRYFCWPNDIUQOW-UHFFFAOYSA-N
InChI=1S/C21H25FN2O2/c1-26-21-7-3-2-5-19(21)24-15-13-23(14-16-24)12-4-6-20(25)17-8-10-18(22)11-9-17/h2-3,5,7-11H,4,6,12-16H2,1H3
Molecular Formula | C21H25FN2O2 |
Molecular Weight | 356.4338 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Fluanisone, a butyrophenone derivative, is a neuroleptic agent, which was used in the treatment of schizophrenia and mania. Veterinary formulation fentanyl/fluanisone (Hypnorm) is used for rodent analgesia during short surgical procedures. Hypnorm is a combination often used as a neuroleptanalgesic and anaesthetic. Fentanyl-fluanisone has stimulating effects on the amount of spike-wave discharges, but not in a dose-dependent manner. A low dose of 0.01 mg/kg fentanyl with 0.5 mg/kg fluanisone causes a large increase in epileptic activity. This effect is larger than with a middle dose of 0.1 mg/kg fentanyl and 5 mg/kg fluanisone and much larger than with a high dose of 0.2 mg/kg fentanyl with 10 mg/kg fluanisone. The last two doses cause a prolonged anaesthetic state in rats. Fluanisone alone in the same doses as in the mixture induces a large dose-dependent increase in spike-wave activity, with only a small effect on spike frequency. This might be caused by the antagonistic action of this drug at dopamine receptors.
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
The bucco-linguo-masticatory syndrome as a side-effect of neuroleptics therapy. | 1967 |
|
A comparison of efficacy and toxicity between electroporation and adenoviral gene transfer. | 2002 Aug 13 |
|
Effects of SERM (selective estrogen receptor modulator) treatment on growth and proliferation in the rat uterus. | 2003 May 7 |
|
Efficient delivery of Cre-recombinase to neurons in vivo and stable transduction of neurons using adeno-associated and lentiviral vectors. | 2004 Jan 30 |
|
Targeted radiosensitisation by pegylated liposome-encapsulated 3', 5'-O-dipalmitoyl 5-iodo-2'-deoxyuridine in a head and neck cancer xenograft model. | 2004 Jul 19 |
|
The tyrosine kinase inhibitor ZD6474 inhibits tumour growth in an intracerebral rat glioma model. | 2004 Sep 13 |
|
Effect of live Salmonella Ty21a in dextran sulfate sodium-induced colitis. | 2007 |
|
Morphological characterization of intra-articular HMGB1 expression during the course of collagen-induced arthritis. | 2007 |
|
Lack of evidence for reduced prefrontal cortical serotonin and dopamine efflux after acute tryptophan depletion. | 2007 Dec |
|
Screening mouse vision with intrinsic signal optical imaging. | 2007 Feb |
|
Lung inflammation and genotoxicity following pulmonary exposure to nanoparticles in ApoE-/- mice. | 2009 Jan 12 |
|
Enterococcal surface protein Esp is not essential for cell adhesion and intestinal colonization of Enterococcus faecium in mice. | 2009 Jan 29 |
|
Integrating statistical predictions and experimental verifications for enhancing protein-chemical interaction predictions in virtual screening. | 2009 Jun |
|
Variation in the phase of response to low-frequency pure tones in the guinea pig auditory nerve as functions of stimulus level and frequency. | 2009 Jun |
|
Listeria monocytogenes infection affects a subset of Ly49-expressing NK cells in the rat. | 2010 Dec 15 |
|
68Ga-chloride PET reveals human pancreatic adenocarcinoma xenografts in rats--comparison with FDG. | 2010 Jun |
|
Forward masking estimated by signal detection theory analysis of neuronal responses in primary auditory cortex. | 2010 Sep |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/12498456
The rabbits were anesthetized with intramuscular injections of fluanisone (0.7 mg/ kg body weight) and diazepam (1.5 mg/kg b.wt.)
Route of Administration:
Intramuscular
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 16:24:15 GMT 2023
by
admin
on
Fri Dec 15 16:24:15 GMT 2023
|
Record UNII |
1D0W98U1I4
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Code | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-ATC |
N05AD09
Created by
admin on Fri Dec 15 16:24:15 GMT 2023 , Edited by admin on Fri Dec 15 16:24:15 GMT 2023
|
||
|
WHO-VATC |
QN05AD09
Created by
admin on Fri Dec 15 16:24:15 GMT 2023 , Edited by admin on Fri Dec 15 16:24:15 GMT 2023
|
||
|
NCI_THESAURUS |
C29710
Created by
admin on Fri Dec 15 16:24:15 GMT 2023 , Edited by admin on Fri Dec 15 16:24:15 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DTXSID4045711
Created by
admin on Fri Dec 15 16:24:15 GMT 2023 , Edited by admin on Fri Dec 15 16:24:15 GMT 2023
|
PRIMARY | |||
|
SUB07662MIG
Created by
admin on Fri Dec 15 16:24:15 GMT 2023 , Edited by admin on Fri Dec 15 16:24:15 GMT 2023
|
PRIMARY | |||
|
1444
Created by
admin on Fri Dec 15 16:24:15 GMT 2023 , Edited by admin on Fri Dec 15 16:24:15 GMT 2023
|
PRIMARY | |||
|
170977
Created by
admin on Fri Dec 15 16:24:15 GMT 2023 , Edited by admin on Fri Dec 15 16:24:15 GMT 2023
|
PRIMARY | |||
|
100000081229
Created by
admin on Fri Dec 15 16:24:15 GMT 2023 , Edited by admin on Fri Dec 15 16:24:15 GMT 2023
|
PRIMARY | |||
|
216-038-8
Created by
admin on Fri Dec 15 16:24:15 GMT 2023 , Edited by admin on Fri Dec 15 16:24:15 GMT 2023
|
PRIMARY | |||
|
C65704
Created by
admin on Fri Dec 15 16:24:15 GMT 2023 , Edited by admin on Fri Dec 15 16:24:15 GMT 2023
|
PRIMARY | |||
|
C005014
Created by
admin on Fri Dec 15 16:24:15 GMT 2023 , Edited by admin on Fri Dec 15 16:24:15 GMT 2023
|
PRIMARY | |||
|
1480-19-9
Created by
admin on Fri Dec 15 16:24:15 GMT 2023 , Edited by admin on Fri Dec 15 16:24:15 GMT 2023
|
PRIMARY | |||
|
FLUANISONE
Created by
admin on Fri Dec 15 16:24:15 GMT 2023 , Edited by admin on Fri Dec 15 16:24:15 GMT 2023
|
PRIMARY | |||
|
CHEMBL58792
Created by
admin on Fri Dec 15 16:24:15 GMT 2023 , Edited by admin on Fri Dec 15 16:24:15 GMT 2023
|
PRIMARY | |||
|
m5416
Created by
admin on Fri Dec 15 16:24:15 GMT 2023 , Edited by admin on Fri Dec 15 16:24:15 GMT 2023
|
PRIMARY | Merck Index | ||
|
1D0W98U1I4
Created by
admin on Fri Dec 15 16:24:15 GMT 2023 , Edited by admin on Fri Dec 15 16:24:15 GMT 2023
|
PRIMARY | |||
|
DB13665
Created by
admin on Fri Dec 15 16:24:15 GMT 2023 , Edited by admin on Fri Dec 15 16:24:15 GMT 2023
|
PRIMARY | |||
|
15139
Created by
admin on Fri Dec 15 16:24:15 GMT 2023 , Edited by admin on Fri Dec 15 16:24:15 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |